Page last updated: 2024-09-04

2'-fluorothymidine and Cancer of Prostate

2'-fluorothymidine has been researched along with Cancer of Prostate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desai, B; Jadvar, H; Varghese, B; Velez, E1
Chen, K; Jadvar, H; Ukimura, O1
Dickow, B; Dobson, K; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Smith, D; Tehrani, OS; Vaishampayan, UN1
Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A1
Douglas, KA; Heilbrun, LK; Lawhorn-Crews, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H; Tehrani, OS1
Bading, JR; Bathija, P; Conti, PS; Shahinian, AH1

Trials

1 trial(s) available for 2'-fluorothymidine and Cancer of Prostate

ArticleYear
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
    Molecular imaging and biology, 2017, Volume: 19, Issue:6

    Topics: Aged; Arabinofuranosyluracil; Biomarkers, Tumor; Bone Neoplasms; Bone Remodeling; Diphosphonates; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Tomography, X-Ray Computed; Zoledronic Acid

2017

Other Studies

5 other study(ies) available for 2'-fluorothymidine and Cancer of Prostate

ArticleYear
Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:7

    Topics: Aged; Arabinofuranosyluracil; Fluorine Radioisotopes; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals

2018
Targeted Prostate Gland Biopsy With Combined Transrectal Ultrasound, mpMRI, and 18F-FMAU PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:8

    Topics: Arabinofuranosyluracil; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed

2015
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal Neoplasms; DNA, Neoplasm; Female; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thymidine; Tissue Distribution

2004
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:9

    Topics: Arabinofuranosyluracil; Brain Neoplasms; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals

2007
Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
    Nuclear medicine and biology, 2000, Volume: 27, Issue:4

    Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA; Male; Prostatic Neoplasms; Rats; Thymidine; Tumor Cells, Cultured

2000